PRO-Spectus Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • PRO-Spectus's estimated annual revenue is currently $20.8M per year.(i)
  • PRO-Spectus's estimated revenue per employee is $155,000

Employee Data

  • PRO-Spectus has 134 Employees.(i)
  • PRO-Spectus grew their employee count by 23% last year.

PRO-Spectus's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
President and CEOReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Chief People & Culture OfficerReveal Email/Phone
7
Chief Technology OfficerReveal Email/Phone
8
VP, Business DevelopmentReveal Email/Phone
9
VP, Pharmacy & Clinical Solutions, Market AccessReveal Email/Phone
10
VP, Market AccessReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is PRO-Spectus?

PRO-Spectus Inc. is a unique company whose primary business is conducted with clients in the pharmaceutical, medical device and diagnostic industries who develop novel products for treatments across a wide variety of patient populations. Our team members apply their experience with patient-reported outcomes, epidemiology, health economics, market access and reimbursement in creative ways to maximize product success. Please see our company's website for more information or drop me a note.

keywords:N/A

N/A

Total Funding

134

Number of Employees

$20.8M

Revenue (est)

23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PRO-Spectus News

2022-04-20 - SDRL: Seadrill Limited announces approval and publication ...

The Company has prepared a prospectus in connection with the listing of the shares on Euronext Expand and the contemplated subsequent transfer...

2022-04-19 - SHAMARAN PUBLISHES SUPPLEMENT TO PROSPECTUS

SHAMARAN PUBLISHES SUPPLEMENT TO PROSPECTUS. Tue, April 26, 2022, 2:30 p.m. ·5 min read. In this article: SHASF. /NOT FOR RELEASE, DISTRIBUTION OR...

2022-04-17 - UK Prospectus Regime Review

Proposed Changes. Changes to prospectus requirement for admission to trade on a U.K. regulated market. The proposed new regime will not change...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.8M13410%$43.8M
#2
$36.2M1347%N/A
#3
$41.3M13422%N/A
#4
$25.3M13412%$69M
#5
$44.2M134-3%N/A